Inbiomotion SL, a company developing a unique single-gene-based biomarker for the personalized adjuvant treatment of early-stage (stage I-III) breast cancer patients, announces the results of comparin...
Read moreResearchers at IBEC manage to recreate the complex composition of human breast tumors in the laboratory using tissues from female pig breasts. This new model will allow, among other applications, the ...
Read moreEl Instituto de Investigación Sanitaria INCLIVA, del Hospital Clínico de València, ha impulsado un estudio para desarrollar un modelo predictivo de diagnóstico diferencial temprano de miomas y mio...
Read moreEighteen months after the first one, the Hospital Clínic carried out its second uterus transplant on 4 April. On this occasion, it was possible thanks to a mother donating her uterus to her daughter,...
Read moreImmature human egg cells skip a fundamental metabolic reaction thought to be essential for generating energy, according to the findings of a study by researchers at the Centre for Genomic Regulation (...
Read moreInvestigadores de distintos grupos CIBERONC demuestran en un estudio colaborativo que la mayoría de los carcinomas mixtos ductales/lobulillares (CMDL)de la mama derivan del componente ductal que, dur...
Read moreDesde 2005, la Unidad de Patología Mamaria de Vall d’Hebron ha atendido a más de 12.000 pacientes con sospecha de cáncer de mama por el circuito de diagnóstico rápido de cáncer, de los cuales ...
Read moreResearchers from the Bellvitge Biomedical Research Institute (IDIBELL), the Catalan Institute of Oncology (ICO) and the University of Innsbruck in Austria have designed and tested a new non-invasive, ...
Read moreEsta herramienta, en la cual el Hospital del Mar es líder en el mundo, ofrece resultados diagnósticos similares a los de la resonancia magnética de mama, el otro instrumento que permite visualizar ...
Read moreDespite early detection in the majority of cases, mortality rates have been rising by 1.9% per year on average. This trend is mainly attributable to the increasing incidence of obesity as a major risk...
Read moreThe University of Barcelona is leading a European project to clinically validate an Artificial Intelligence solution to predict the specific response of each patient in breast cancer chemotherapy.
Read more